Evidence map›Paper›PMID 36330515›Full record

ReviewFrontiers in immunology2022

Neonatal sepsis and transient immunodeficiency: Potential for novel immunoglobulin therapies?

Coco R Beudeker, Daniel C Vijlbrief, Joris M van Montfrans, Suzan H M Rooijakkers, Michiel van der Flier

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Maternal and neonatal IgG againstmedRxiv : the preprint server for health sciences · 2024
    Article
  19. Article
  20. The potential role of heparin-binding protein in neonatal sepsis: research progress.Frontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Coco R BeudekerDepartment of Pediatric Infectious Diseases and Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Daniel C VijlbriefDepartment of Neonatology, University Medical Center Utrecht, Utrecht, Netherlands.
Joris M van MontfransDepartment of Pediatric Infectious Diseases and Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Suzan H M RooijakkersDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands.
Michiel van der FlierDepartment of Pediatric Infectious Diseases and Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
University Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonates, especially preterm neonates, have the highest risk of sepsis of all age groups. Transient immaturity of the neonatal immune system is an important risk factor. Neonates suffer from hypogammaglobulinemia as nor IgA nor IgM is transferred over the placenta and IgG is only transferred over the placenta late in gestation. In addition, neutrophil numbers and complement function are also decreased. This mini-review focuses on strategies to improve neonatal host-defense. Both clinical and preclinical studies have attempted to boost neonatal immunity to lower the incidence of sepsis and improve outcome. Recent advances in the development of (monoclonal) antibodies show promising results in preclinical studies but have yet to be tested in clinical trials. Strategies to increase complement activity seem efficient

Indexed as

Immunologic Deficiency SyndromesNeonatal SepsisSepsisFemaleHumansImmunoglobulinsInfant, NewbornNeutrophilsPregnancyImmunoglobulinscomplement systemimmunodeficiencyimmunoglobulin therapymonoclonal antibodiesneonatal sepsisneutrophil function

Identifiers

PMID36330515
PMCPMC9623314
OpenAlexW4306684270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.